Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Mf Beauty Partners LLC has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. The workload is distributed across 3 distinct examiners, with each examiner handling a single matter. This distribution is further reflected in the 3 distinct art units involved in the current prosecution. Such a structure indicates that the company's patent filings are technically diverse, touching upon multiple specialized disciplines within the broader biotechnology and pharmaceutical landscape.
The busiest examiner, TRAN, SUSAN T, is responsible for 1 pending office action. Because the 3 pending office actions are spread across 3 distinct art units, the company must address a variety of technical perspectives and examination standards. The involvement of 3 distinct examiners means that prosecution outcomes are not dependent on a single individual's interpretation of the law. This diversification can protect the portfolio from systemic delays if a single art unit or examiner has a high backlog or strict rejection rate.
Managing the current pending office actions across multiple examiners requires a coordinated effort to ensure that the company's overall IP strategy remains consistent. While each of the assigned art units may have its own nuances, the shared focus on Biotechnology & Pharmaceuticals provides a unifying theme. The applicant should be prepared to tailor their arguments to the specific requirements of each examiner, including TRAN, SUSAN T, while maintaining a cohesive narrative across the entire pending portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, SUSAN T | 1 | 62.8% | +35.1% |
| JOHNSON, DANIELLE D | 1 | 45.0% | +12.9% |
| PRAGANI, RAJAN | 1 | 53.3% | +70.0% |
| LIU, TRACY | 1 | 54.5% | +27.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918820 | High-Potency Vitamin C Chemical Peeling Solutions | PRAGANI, RAJAN | 12d |
| 18653884 | ANHYDROUS BARRIER AND ANTIOXIDANT COMPOSITIONS | TRAN, SUSAN T | — |
| 17918826 | Anhydrous Azelaic Acid Topical Formulations | JOHNSON, DANIELLE D | — |
| 17918823 | Anhydrous Urea Emulsions | LIU, TRACY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918820 | High-Potency Vitamin C Chemical Peeling Solutions | PRAGANI, RAJAN | 12d |
| 18653884 | ANHYDROUS BARRIER AND ANTIOXIDANT COMPOSITIONS | TRAN, SUSAN T | — |
| 17918826 | Anhydrous Azelaic Acid Topical Formulations | JOHNSON, DANIELLE D | — |
| 17918823 | Anhydrous Urea Emulsions | LIU, TRACY | — |
| Art Unit | Apps |
|---|---|
| 1614 | 2 |
| 1615 | 1 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18653884 | ANHYDROUS BARRIER AND ANTIOXIDANT COMPOSITIONS | TRAN, SUSAN T | 1615 | §102§103§112 | Non-Final OA | — | Pending | May 02, 2024 |
| 17918826 | Anhydrous Azelaic Acid Topical Formulations | JOHNSON, DANIELLE D | 1617 | §103§112Other | Non-Final OA | — | Pending | Oct 13, 2022 |
| 17918820 | High-Potency Vitamin C Chemical Peeling Solutions | PRAGANI, RAJAN | 1614 | §103§112Other | Final Rejection | 12d | Pending | Oct 13, 2022 |
| 17918823 | Anhydrous Urea Emulsions | LIU, TRACY | 1614 | §103§112 | Non-Final OA | — | Pending | Oct 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial